Search - tctmd.com

Displaying 281 - 300 of 383

Sort: Relevancy | Date

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Daily News

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Michael O'Riordan

October 31, 2018

News Daily News

Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors

L.A. McKeown

October 30, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Daily News

Beta-blocker Use in Pregnancy Doesn’t Up Birth Defect Risk, Study Suggests

Caitlin E. Cox

October 15, 2018

News Daily News

Church-Based Lifestyle Intervention Shows Promise for Lowering BP in Hypertensive African-Americans

Todd Neale

October 09, 2018

News Daily News

Ronald G. Victor, Who Brought Hypertension Treatment Into the Barbershop, Dead at 66

Todd Neale

September 14, 2018

News Daily News

Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’

Todd Neale

September 13, 2018

News Daily News

Pharmacist-Led BP Telemonitoring Intervention Works Up to 1 Year After Program Stops

Yael L. Maxwell

September 10, 2018

News Conference News ESC 2018

ASCOT Legacy: Calcium Channel Blockers, Statins Confer Long-term Survival Benefits in Hypertensive Patients

L.A. McKeown

August 31, 2018

News Conference News ESC 2018

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

Michael O'Riordan

August 26, 2018

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction

Shelley Wood

August 15, 2018

News Industry News

Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

August 14, 2018

Podcast Heart Sounds

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

News Daily News

Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests

L.A. McKeown

May 23, 2018

News Daily News

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Michael O'Riordan

May 10, 2018

News Daily News

Uptick Seen in Medication Adherence Among Hypertensive Patients Using Mobile App

Michael O'Riordan

April 16, 2018

News Daily News

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Michael O'Riordan

April 09, 2018

Advertisement

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Study Questions Role of BP Meds in Patients With Hypertension but No Other CVD Risk Factors

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Beta-blocker Use in Pregnancy Doesn’t Up Birth Defect Risk, Study Suggests

Church-Based Lifestyle Intervention Shows Promise for Lowering BP in Hypertensive African-Americans

Ronald G. Victor, Who Brought Hypertension Treatment Into the Barbershop, Dead at 66

Lack of Short-term Cancer Risk With Tainted Valsartan ‘Reassuring’

Pharmacist-Led BP Telemonitoring Intervention Works Up to 1 Year After Program Stops

ASCOT Legacy: Calcium Channel Blockers, Statins Confer Long-term Survival Benefits in Hypertensive Patients

Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

TRIUMPH in Print: Triple-Drug Polypill Shines for Fast, Safe Blood Pressure Reduction

Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

Top Stories in Cardiology: May 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Lower BP Targets Can Save Over 300,000 Lives a Year, Analysis Suggests

PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations

Uptick Seen in Medication Adherence Among Hypertensive Patients Using Mobile App

Pills or Even Tea More Palatable Than Exercise for the Treatment of Hypertension, US Adults Say

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content